Aligos Therapeutics Inc. (NASDAQ: ALGS) Stock Information | RedChip

Aligos Therapeutics Inc. (NASDAQ: ALGS) Listen to this Section


$0.48
-0.0130 ( -2.64% ) 1.0M

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Market Data


Open


$0.48

Previous close


$0.49

Volume


1.0M

Market cap


$38.36M

Day range


$0.44 - $0.54

52 week range


$0.35 - $1.20

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 2 Aug 09, 2024
3 Insider transactions 2 Aug 09, 2024
4 Insider transactions 1 Aug 09, 2024
4 Insider transactions 1 Aug 09, 2024
8-k 8K-related 13 Aug 08, 2024
10-q Quarterly Reports 74 Aug 06, 2024
8-k 8K-related 15 Aug 06, 2024
8-k 8K-related 15 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 28, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.